in God We TrustNumber 1 site to help prevent and reverse all diseases In God we Trust
 

 

 
Home
Diagnosis
Treatment

Deodorants cause Breast

Women Heart attack
Women risk diseases
Women stroke Risk
Women Killer Disease
Women ER delay
Diet
Inner Ear Disease
Services Page
Autoimmune diseases
Bible healing
Personality
Hair & Chemicals
Fibromyalgia
Bras & Breast Cancer
Women sex issues
Mammogram cancer
Breast Massage
Breast Implants
Breast Exam
Breast Lymph
Memory problems
Bra Chemicals
Breast Cancer Herbs
Rheumatic Disorders
Breast nutrients
Circadian Rhythm
Cancer
 Cancer Book

Heart disease & stroke 

Learn  about Brain

Kamut Grain

contact by service link  Welcome to the CIDP USA Foundation
    Read contents of E-Book for complete prevention & treatment of Heart disease

Women at greater risk for autoimmune diseases with ocular manifestations

  episcleritis

 help press  heart

Communication with physicians managing the patient’s systemic disease is crucial.

By Katrina Altersitz 

Women are as much as 50 times more likely to suffer from certain autoimmune diseases than men, and these diseases often have ocular manifestations that ophthalmologists should be aware of when examining their female patients, experts say.

“Autoimmune diseases are the No. 1 example of the higher risk” women carry for certain diseases due to sex, said Janine A. Smith, MD, of the National Eye Institute. “There are a lot of autoimmune diseases, and nearly every single one affects women more than men.”

Stress in life and from pregnancy and monthly periods are know issues.

Sjögren’s syndrome, with its symptoms of dry eye and dry mouth, is a prime example of an autoimmune disease seen more often in women. In addition, she said, systemic lupus erythematosus, rheumatoid arthritis and thyroid disease all disproportionately affect women, and all can have ophthalmic manifestations.

One theory, is that because estrogens are naturally proinflammatory and androgens, specifically testosterone, are considered anti-inflammatory, women are more prone to developing autoimmune problems.

 Lupus

Systemic lupus erythematosus, a collagen vascular disease, affects women nine times as often as men. Typically young, middle-aged women are affected, said C. Stephen Foster, MD.

Lupus often causes dry eye, for which treatment is much like that for Sjögren’s syndrome, but there are other possible ocular complications as well.

“It might be something as relatively trivial as a rash, a low grade subtle dermatitis on the lid, or something that is directly relating to the eyeball itself with episodes of superficial inflammation,” he said. “This superficial inflammation may be affecting only the conjunctiva or, more prominently, it will be episodic inflammation of the tissues deeper to the conjunctiva like the episclera or sclera.”

Recurring episcleritis is a “trivial” but common ocular complication of lupus, Dr. Foster said. While it rarely requires aggressive therapy, episodes are often treated with corticosteroid drops, which can have long-term consequences, he explained.

“Eventually there is a price to pay, most particularly with respect to development to cataract,” he said. “We believe taking an oral nonsteroidal anti-inflammatory medication is the most productive and appropriate way to address that.”

Keratitis is another ocular manifestation of lupus. Patients can develop peripheral keratitis or multifocal superficial corneal inflammation, leaving small nebulae in the superficial cornea stroma.

“Both of them are associated with light sensitivity and photophobia. Both are important because they both carry with them a little more prognostic significance than does episcleritis or conjunctivitis,” Dr. Foster explained. “Both are fairly disabling because of the photophobia.”

Kathryn Colby, MD, PhD
Kathryn Colby
 

He said, again, corticosteroids are usually used for treatment, but the long-term solution for keratitis is to address the underlying lupus with systemic medication.

The systemic manifestations of lupus make it a potentially life threatening disorder, said Kathryn Colby, MD, PhD.

“The treatment is first identification of the systemic disease associated with it,” she said. “Often, management of the systemic disease will help with the ocular manifestations.”

Unfortunately, Drs. Colby and Foster said, Plaquenil (hydroxychloroquine, Sanofi Winthrop), the traditional systemic treatment for lupus, can cause damage to the retina when used in high dosage.

continued to page-2